Cargando…
Itaconate as an inflammatory mediator and therapeutic target in cardiovascular medicine
Inflammation is a critical component of cardiovascular disease (CVD), encompassing coronary artery disease (CAD), cerebrovascular events and heart failure and is the leading cause of mortality worldwide. In recent years, metabolism has been placed centrally in the governance of the immune response....
Autores principales: | Diotallevi, Marina, Ayaz, Faseeha, Nicol, Thomas, Crabtree, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589439/ https://www.ncbi.nlm.nih.gov/pubmed/34665229 http://dx.doi.org/10.1042/BST20210269 |
Ejemplares similares
-
Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation
por: Bailey, Jade D., et al.
Publicado: (2019) -
Therapeutic potential of tricarboxylic acid cycle metabolite itaconate in cardiovascular diseases
por: Yang, Chongzhe, et al.
Publicado: (2020) -
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
por: Lin, Jiaqi, et al.
Publicado: (2021) -
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021) -
The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases
por: Shi, Xuan, et al.
Publicado: (2022)